Search research articles
Contact Us
Filters
Showing results (1-10 of 105) with videos related to
Page
of 11
Sort By:
AJR. American Journal of Roentgenology
|
March 26, 2025
Beyond the <i>AJR</i>: When Nonmetastatic Disease Is No Longer Nonmetastatic
Amir Iravani
The Journal of Urology
|
December 4, 2019
Editorial Comment
Amir Iravani
Radiology
|
June 30, 2026
Salvage Radiotherapy Decision-making in the Era of Molecular Imaging: Insights from EMPIRE-2
Amir Iravani
Seminars in Nuclear Medicine
|
December 19, 2025
Therapy strategies to defeat prostate cancer heterogeneity
Hossein Jadvar, Amir Iravani
PET Clinics
|
March 8, 2017
Gallium-68 Prostate-Specific Membrane Antigen PET Imaging
Michael S Hofman, Amir Iravani
Radiology. Imaging Cancer
|
November 28, 2025
PSMA PET-guided Intensification of Salvage Radiotherapy after Radical Prostatectomy
Ridvan A Demirci, Amir Iravani
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2021
RESIST-PC: U.S. Academic Foray into PSMA Theranostic Trials
Amir Iravani, Thomas A Hope
Clinical Nuclear Medicine
|
January 22, 2015
The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer: a case of osteolytic prostate metastasis
Amir Iravani Tabrizipour, Marina Dunne
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 24, 2020
Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 1: The Role of <sup>18</sup>F-FDG PET/CT
Amir Iravani, Rodney J Hicks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2020
Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 2: The Role of Novel PET Agents
Amir Iravani, Rodney J Hicks
Page
of 11
Search research articles
Search
Showing results (1-10 of 105) with videos related to
Sort By:
Page
of 11
AJR. American Journal of Roentgenology
|
March 26, 2025
Beyond the <i>AJR</i>: When Nonmetastatic Disease Is No Longer Nonmetastatic
Amir Iravani
The Journal of Urology
|
December 4, 2019
Editorial Comment
Amir Iravani
Radiology
|
June 30, 2026
Salvage Radiotherapy Decision-making in the Era of Molecular Imaging: Insights from EMPIRE-2
Amir Iravani
Seminars in Nuclear Medicine
|
December 19, 2025
Therapy strategies to defeat prostate cancer heterogeneity
Hossein Jadvar, Amir Iravani
PET Clinics
|
March 8, 2017
Gallium-68 Prostate-Specific Membrane Antigen PET Imaging
Michael S Hofman, Amir Iravani
Radiology. Imaging Cancer
|
November 28, 2025
PSMA PET-guided Intensification of Salvage Radiotherapy after Radical Prostatectomy
Ridvan A Demirci, Amir Iravani
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2021
RESIST-PC: U.S. Academic Foray into PSMA Theranostic Trials
Amir Iravani, Thomas A Hope
Clinical Nuclear Medicine
|
January 22, 2015
The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer: a case of osteolytic prostate metastasis
Amir Iravani Tabrizipour, Marina Dunne
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 24, 2020
Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 1: The Role of <sup>18</sup>F-FDG PET/CT
Amir Iravani, Rodney J Hicks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2020
Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 2: The Role of Novel PET Agents
Amir Iravani, Rodney J Hicks
Page
of 11